Sabcs Review - Search Videos

SABCS 2025: Translating Evidence Into Practice in HR /HER2‑ Breast Cancer

SABCS 2025: Translating Evidence Into Practice in HR /HER2‑ Breast Cancer

SABCS 2024 Review: Evaluating the Role of Adjuvant ET in Low-Risk DCIS Management

SABCS 2024 Review: Evaluating the Role of Adjuvant ET in Low-Risk DCIS Management

SABCS 2025 Summary: ADC Resistance in Breast Cancer

SABCS 2025 Summary: ADC Resistance in Breast Cancer

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

A review of the SABC’s coverage of the Elections 2024 by Analyst, Researcher and Commentator @mighti_jamie. Stream SABC News Elections Pop-Up channel live on SABCPlus. | SABC

A review of the SABC’s coverage of the Elections 2024 by Analyst, Researcher and Commentator @mighti_jamie. Stream SABC News Elections Pop-Up channel live on SABCPlus. | SABC

274 viewsMay 31, 2024

EFF rejects SABC’s new editorial structure - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

EFF rejects SABC’s new editorial structure - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

A review of SABC's comprehensive coverage of the 2024 elections through our television, radio, and online platforms, ensuring that all South African citizens are well-informed and educated. | SABC

A review of SABC's comprehensive coverage of the 2024 elections through our television, radio, and online platforms, ensuring that all South African citizens are well-informed and educated. | SABC

215 viewsJun 10, 2024

SABCS 2024 Summary: Advancing Breast Cancer Detection With Novel Imaging Technologies

SABCS 2025: Insights on Key Advances in HR /HER2- Breast Cancer

Welcome back to SABCS Sips—your recap of breakthroughs and updates from the San Antonio Breast Cancer Symposium (@sabreastcancersymposium)! ☕ Today’s #SABCS24 highlights feature: 🔬 Groundbreaking findings on BRCA2 gene variants by BCRF investigator Fergus Couch 💡 Promising updates on DCIS treatment approaches 🤖 AI’s transformative role in personalizing breast cancer care And a huge congrats to BCRF investigator Dr. Steffi Oesterreich on receiving the AACR Distinguished Lectureship Award! 👏 S

232 viewsDec 13, 2024

FacebookThe Breast Cancer Research Foundation

Highlights in ER Breast Cancer From SABCS 2025

SABCS 2024 Summary: Highlights in Breast Cancer Genomic Testing - A Guide to Precision Treatment

418 viewsJan 17, 2025

SABCS 2025: Previewing New Data in HR /HER2- Breast Cancer

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, INSEMA, and OlympiA Trials in Breast Cancer Management

907 viewsJan 2, 2025

SABCS 2025 Insights: SLNB vs. Omission in eBC - Impact on Systemic and Radiation Therapy

SABCS 2025 Summary: Evolving Data for PALB2, ATM, and CHEK2 Carriers With Breast Cancer

SABCS 2024 Insights: Impact of Oncotype DX Risk Stratification on Chemotherapy Use and Survival Outcomes in HR Node- eBC

SABCS 2022 Primary Results From the Randomized Phase II RIGHT Choice Trial: Premenopausal Patients With Aggressive HR /HER2- Advanced BC Treated With Ribociclib ET vs. Physician’s Choice Combination Chemo

SABCS 2025 Insights: Clinical Outcomes of Invasive Lobular Carcinoma vs. Non-Lobular Breast Cancer Assessed by Pathologists, AI CDH1 Classifier, and AI-Derived TME Biomarkers in TAILORx

Live from SABCS, the world’s largest breast cancer conference, we’re joined by patient advocate @theanniebond to share the metastatic breast cancer perspective and what she’s most looking forward to this year. ✨ BCRF-funded investigators have patients at the center of every research study, keeping quality of life balanced with treatment efficacy at the heart of their work. Stay tuned for more coverage and key takeaways from #SABCS25 coming soon! *Editor’s Note: SABCS began in 1978, while the fir

4.8K views5 months ago

FacebookThe Breast Cancer Research Foundation

We’re at SABCS with Dr. Gaorav Gupta, who is offering new insight into a question that has long evaded answers: Can immunotherapy be effective in hormone receptor-positive (HR ) breast cancer? Immunotherapy has had some success in triple-negative breast cancer, but not as much in other subtypes. Dr. Gupta’s study tested whether delivering focused radiation w/pembro prior to surgery could create an immune-stimulating signal that makes immunotherapy more effective for HR /HER2- breast cancers. Ear

9.2K views5 months ago

FacebookThe Breast Cancer Research Foundation

Started off SABCS with a session on breast cancer risk and alcohol 🍷 use. I go into this in the video but I want to stress that this is NOT to cause blame or shame for anyone. Alcohol is just one of many cancer risk factors but we also know that many Americans are not aware or unsure about alcohol and cancer risk so it is an important discussion to have. You are NOT to blame for a cancer diagnosis. In this video, I discuss 5 key points on alcohol: amount and risk, type of alcohol and risk, impa

18K views5 months ago

FacebookEleonora Teplinsky, MD

New research shared at SABCS 2025 suggests that being physically active may lower breast cancer risk — no matter your reproductive history. In a large UK study, higher activity levels were linked to a lower overall risk of breast cancer, consistent across age at first period, menopause timing, childbirth history, and hormone use. Link in bio for more research updates coming out of San Antonio. #breastcancer #SABCS25 #breastcancersupport #breastcancerawareness #breastcancer #cancerresearch #breas

11K views5 months ago

FacebookBreastcancer.org

A major update from SABCS: BCRF investigator Dr. Aditya Bardia shares encouraging results from the lidERA trial, studying a new hormone therapy called giredestrant for early HR breast cancer. In the trial, giredestrant lowered the risk of cancer coming back and showed fewer treatment-related side effects, meaning it may be both more effective and easier to stay on than current options. If approved, it could become the first new adjuvant endocrine therapy in decades. FDA review is expected in 202

11.4K views5 months ago

FacebookThe Breast Cancer Research Foundation

Can I Sue Someone for a Bad Review Against My Business?

SABCS 2025: The latest developments in multigene testing in early breast cancer

SABCS Advocacy | Hot Topic Sessions | ABCF

alamobreastcancer.org

How To Play Sabacc

39.1K viewsApr 13, 2018

YouTubeSabacc Chat

Opening to Blue's Clues: ABC's & 123's 1999 VHS

260.6K viewsFeb 16, 2020

YouTubeMoose and Zee

Opening To Blue's Clues:ABC's And 123's 1999 VHS

2.8M viewsAug 2, 2012

YouTubethepreviewsguyvhs&dvdopeningsalter

See more